Sort
40,608 grants matching “prostate cancer”
Targeting AR and AR-Variants in Castration-Resistant Prostate Cancer
$448,531Chendil Damodaran · Texas A&M University Health Science Ctr · R01 · FY2023 · CA
BKV and JCV vaccine development
$448,512Christopher Buck · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance
$448,510Moran Amit · University Of Tx Md Anderson Can Ctr · R37 · FY2023 · CA
Maryland Prostate Cancer Case-Control Study
$448,501Stefan Ambs · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
TARGETING THE HSP40/HSP70 MOLECULAR CHAPERONE AXIS AS A NOVEL TREATMENT STRATEGY FOR CASTRATE-RESISTANT PROSTATE CANCER
$448,499The Geneva Foundation · · FY2016 · Defense Health Agency
Estimating the Potential Medicare Savings from Comparative Effectiveness Research
$448,490Alan M Garber · Harvard Medical School · R37 · FY2011 · AG
PROSTATE CANCER PROGNOSTICS BASED ON GENOME ARCHITECTURE
$448,466The Geneva Foundation · · FY2015 · Department of the Army
Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients
$448,440Amy Jude Hoffman · University Of Nebraska Medical Center · R01 · FY2022 · CA
Development of Next Generation Galeterone Analogs for Prostate Cancer Therapy
$448,418Vincent Collins Ofuka Njar · University Of Maryland Baltimore · R01 · FY2018 · CA
Development of Next Generation Galeterone Analogs for Prostate Cancer Therapy
$448,418Vincent Collins Ofuka Njar · University Of Maryland Baltimore · R01 · FY2021 · CA
Development of Next Generation Galeterone Analogs for Prostate Cancer Therapy
$448,418Vincent Collins Ofuka Njar · University Of Maryland Baltimore · R01 · FY2020 · CA
PROGRAM LEADERS
$448,297Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2010 · CA
Molecular Genetic Dissection of Photoreceptor Function
$448,268William L Pak · Purdue University · R01 · FY2006 · EY
Modulators of Prostate Cancer Metastasis
$448,251Bruce R Zetter · Boston Children'S Hospital · R01 · FY2015 · CA
The MT1-MMP/RANKL/RANK Axis in Prostate Cancer Bone Metastasis
$448,236Michael L Cher · Wayne State University · R01 · FY2009 · CA
Efficacy and Mechanisms of Resistance to Neoadjuvant Intensive Androgen Signaling Inhibition
$448,227Mary E Taplin · Dana-Farber Cancer Inst · P50 · FY2025 · CA
Imaging Habitats in Sarcoma
$448,046Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2017 · CA
Intrinsic and extrinsic control of epithelial tissue stem cell activity
$448,029Xing Dai · University Of California-Irvine · R35 · FY2022 · GM
Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence
$448,006Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Nuclear Factor-kappaB in Ovarian Cancer
$447,991Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Lectin Resistant Tumor Cells and Functional Glycomics
$447,991Pamela M Stanley · Albert Einstein College Of Medicine · R01 · FY2021 · GM
Lectin Resistant Tumor Cells and Functional Glycomics
$447,991Pamela M Stanley · Albert Einstein College Of Medicine · R01 · FY2022 · GM
Estimating and Mitigating Thyroid Cancer Overdiagnosis: A Mathematical Modeling Approach
$447,964David O. Francis · University Of Wisconsin-Madison · R01 · FY2022 · CA
Cancer in adults following in utero and early life exposure to arsenic
$447,717Craig M Steinmaus · University Of California Berkeley · R01 · FY2014 · ES
Project 2: Combined CAR-T cell therapy
$447,559Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA